[Federal Register Volume 62, Number 170 (Wednesday, September 3, 1997)]
[Notices]
[Page 46504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-23288]
[[Page 46504]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to Section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a
teleconference meeting of the Advisory Committee to the Director,
National Cancer Institute.
This meeting will be open to the public as indicated below, with
attendance by the public limited to space available. Individuals who
plan to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify Linda
Quick-Cameron, Committee Management Officer, National Cancer Institute,
Executive Plaza North, Room 609, 6130 Executive Blvd., MSC 7410,
Bethesda, MD 20892-7410 (301/496-5708). A summary of the meeting and
the roster of committee members will be provided upon request. Other
information pertaining to the meeting may be obtained from the contact
person indicated below.
Committee Name: Advisory Committee to the Director, National
Cancer Institute.
Date: September 18, 1997.
Place: National Institutes of Health, Building 31 Conference
Room 7, 9000 Rockville Pike, Bethesda, MD 20892.
Open: 3 p.m. to 4:30 p.m.
Agenda: Update on the progress of the NCI Working Groups.
Contact Person: Susan J. Waldrop, Executive Secretary, National
Cancer Institute, Federal Building Room 312, 7550 Wisconsin Avenue
(MSC 9010), Bethesda, MD 20892-9010, 301-496-1458.
Dated: August 26, 1997.
LaVeen Ponds,
Policy Analyst, NIH, CMO.
[FR Doc. 97-23288 Filed 9-2-97; 8:45 am]
BILLING CODE 4140-01-M
